Murono Shigeyuki, Yagi-Nakanishi Sayaka, Endo Kazuhira, Kondo Satoru, Sugimoto Hisashi, Yoshizaki Tomokazu
Department of Otolaryngology, Fukushima Medical University.
Department of Otolaryngology-Head and Neck Surgery, Kanazawa University.
Tohoku J Exp Med. 2025 Aug 8;266(4):335-342. doi: 10.1620/tjem.2024.J142. Epub 2024 Dec 12.
Allergic rhinitis, especially Japanese cedar pollinosis, is considered a national affliction in Japan. The present exploratory study focused on the AllergoOncologic aspect of head and neck cancer (HNC) from the perspective of serum allergen-specific IgE against Japanese cedar pollen (JCP) for the first time. Serum JCP-specific IgE was measured in seventy-five HNC patients, including the oropharynx, hypopharynx, and larynx, and seventeen nasopharyngeal cancer (NPC) patients as well as forty-two patients with non-allergic benign disease (nABD). The JCP-specific IgE-positive rate was significantly lower in HNC than nABD (p = 0.037). Similarly, there was a clear trend toward a lower JCP-specific IgE score in HNC than nABD (p = 0.069). Further analyses excluding subjects in their 70s or older also showed that the JCP-specific IgE-positive rate was significantly lower in HNC than nABD (p = 0.022). In addition, The JCP-specific IgE score was significantly lower in HNC than nABD (p = 0.045). A lower serum JCP-specific IgE-positive rate in patients with HNC compared with nABD was demonstrated for the first time. An inverse correlation between HNC and Japanese cedar pollinosis was suggested from the perspective of allergen-specific IgE.
变应性鼻炎,尤其是日本雪松花粉症,在日本被视为一种全国性的疾病。本探索性研究首次从血清变应原特异性IgE针对日本雪松花粉(JCP)的角度,聚焦于头颈癌(HNC)的变应肿瘤学方面。对75名头颈癌患者(包括口咽、下咽和喉癌患者)、17名鼻咽癌(NPC)患者以及42名非变应性良性疾病(nABD)患者检测了血清JCP特异性IgE。头颈癌患者中JCP特异性IgE阳性率显著低于非变应性良性疾病患者(p = 0.037)。同样,头颈癌患者的JCP特异性IgE评分也明显有低于非变应性良性疾病患者的趋势(p = 0.069)。进一步排除70岁及以上受试者的分析也表明,头颈癌患者中JCP特异性IgE阳性率显著低于非变应性良性疾病患者(p = 0.022)。此外,头颈癌患者的JCP特异性IgE评分显著低于非变应性良性疾病患者(p = 0.045)。首次证明了头颈癌患者血清JCP特异性IgE阳性率低于非变应性良性疾病患者。从变应原特异性IgE的角度提示了头颈癌与日本雪松花粉症之间存在负相关。